Viatris to contribute its biosimilars portfolio to Biocon Biologics for up to $3.335 billion, shares jump 4% premarket Finances February 28, 2022 [ad_1] Viatris Inc. VTRS, +4.38%, the corporate fashioned by the merger of Mylan and Pfizer Inc. PFE, +3.83% unit Upjohn…
Episode #392: Laurens Swinkels, Robeco – The Global Market Portfolio, (Realistic) Expected Returns & Global Factor Premiums – Meb Faber Research Finances February 21, 2022 [ad_1] Episode #392: Laurens Swinkels, Robeco – The International Market Portfolio, (Reasonable) Anticipated Returns & International Issue Premiums Visitor: Laurens Swinkels…
